dehydroepiandrosterone sulfate has been researched along with Adenoma, Prostatic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botto, H; Dreyfus, JF; Fiet, J; Ghoneim, TP; Giton, F; Lebret, T; Neuzillet, Y; Radulescu, C; Raynaud, JP | 1 |
| Allifranchini, E; Bocchietto, E; Detering, M; Koyyalamudi, SR; Steels, E; Vitetta, L | 1 |
| Corrales Hernández, JJ; García Diez, LC; Hoisaeter, PA; Martin, T; Miralles García, JM; Montero Gómez, J | 1 |
| Eri, LM; Haug, E; Tveter, KJ | 2 |
| Aydos, K; Küpeli, B; Küpeli, S; Ozdiler, E; Soygür, T | 1 |
| Lewis, CM; Meikle, AW; Middleton, RG; Stephenson, RA; Wiebke, GA | 1 |
| Adami, HO; Mantzoros, CS; Signorello, LB; Stampfer, M; Trichopoulos, D; Tzonou, A | 1 |
| Graff, J; Nieschlag, E; Schürmeyer, T; Senge, T | 1 |
| Albert, J; Geller, J; Kirshner, M; Liu, J | 1 |
3 trial(s) available for dehydroepiandrosterone sulfate and Adenoma, Prostatic
| Article | Year |
|---|---|
Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Ageratum; Anti-Inflammatory Agents; Biomarkers; Blood Glucose; Cell Line; Cholestenone 5 alpha-Reductase; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Humans; Hydrocortisone; Kallikreins; Male; Middle Aged; Plant Extracts; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Urination | 2017 |
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Nitriles; Prolactin; Prostatic Hyperplasia; Testosterone; Tosyl Compounds | 1995 |
Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia.
Topics: Aged; Androstenedione; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Male; Placebos; Prostatic Hyperplasia | 1996 |
7 other study(ies) available for dehydroepiandrosterone sulfate and Adenoma, Prostatic
| Article | Year |
|---|---|
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
Topics: Aged; Androstenediol; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Estrone; Gas Chromatography-Mass Spectrometry; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostatic Hyperplasia; Testosterone; Urinary Bladder Neoplasms | 2017 |
Relations between circulating levels of testosterone, 17 beta-estradiol, androstenedione, dehydroepiandrosterone sulfate, and androgenic receptor content of cytosol in benign prostatic hyperplasia.
Topics: Aged; Androgens; Androstenedione; Cytosol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Testosterone | 1983 |
The role of cigarette smoking in prostatic enlargement.
Topics: Aged; Body Weight; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Humans; Male; Middle Aged; Prostatic Hyperplasia; Smoking; Testosterone | 1997 |
Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
Topics: Adult; Aged; Aging; Body Mass Index; Body Weight; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Electric Impedance; Environment; Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone; Twins, Dizygotic; Twins, Monozygotic | 1997 |
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
Topics: Aged; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Estradiol; Greece; Humans; Insulin-Like Growth Factor I; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay; Risk Factors; Sex Hormone-Binding Globulin; Testosterone | 1997 |
Effect of oestrogen or cyproterone acetate treatment on adrenocortical function in prostate carcinoma patients.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Circadian Rhythm; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Estradiol; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1986 |
Acute effects of testicular and adrenal cortical blockade on protein synthesis and dihydrotestosterone content of human prostate tissue.
Topics: Adrenal Cortex; Aged; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Epithelium; Humans; Hydrocortisone; Male; Megestrol; Megestrol Acetate; Middle Aged; Prostate; Prostatic Hyperplasia; Protein Biosynthesis; Testis; Testosterone | 1985 |